Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Dec 20, 2024 · Filed Dec 26, 2024
Biocardia's Senior Vice President, Devices sold $6.5K of Biocardia shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$6,514
Shares × reported transaction price
37 days after results of Nov 13, 2024, 96 days before results of Mar 26, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −6.1% | −0.5% | −5.6% |
| 30 days | −7.7% | +0.7% | −8.4% |
| 90 days | +8.9% | −4.7% | +13.6% |
| 180 days | −8.5% | +2.0% | −10.6% |
| 365 days | −50.0% | +15.6% | −65.6% |
Past results only. Not a forecast.
Insider buying
Traded Dec 23, 2024 · filed 3 days later
The CEO of Biocardia paid $2.1K out of pocket for Biocardia shares.
Insider buying
Traded Dec 5, 2024 · filed 4 days later
The CEO of Biocardia paid $555 out of pocket for Biocardia shares.
Insider buying
Traded Nov 15, 2024 · filed 4 days later
The CEO of Biocardia paid $2.5K out of pocket for Biocardia shares. It was the first purchase in over a year.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.